Lost password ?
Gulf Pharmaceutical
Growth outlook cut on several medicines removals
- "Following the release of disappointing set of FY18 figures marked by a net loss of AED-153.5m and an almost 30% fall in top-line, we cut our revenue and margins estimates to factor in a more ..."
Executive summary
Conflicts of Interest
FIND A REPORT
SIMPLE, TO THE POINT IDEA GENERATION
Each company is researched in depth using a structured, robust and transparent process. Valuations are disciplined and dispassionate.
AlphaMena allows you to compare stocks along a wide range of parameters be it by sector, by geography or an array of investment themes.
Our reports include actuarial as well as off balance-sheet data and governance metrics.
Priority is given to idea generation through quick, to the point, answers by means of browsing from one idea to the next.